BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in secondary progressive multiple sclerosis (SPMS), but it is unclear whether they are associated with physical and cognitive disability. OBJECTIVE: To investigate the association between MRI outcomes and physical and cognitive disability worsening in people with SPMS. METHODS: We used data from ASCEND, a large randomized controlled trial ( RESULTS: We found no association between MRI measures and EDSS or SDMT worsening. T25FW worsening at 48 and 96 weeks, and NHPT worsening at 96 weeks were associated with cumulative new or newly enlarging T2 lesions at 96 weeks. NHPT worsening at 48 and 96 weeks was associated with normalized brain volume loss a...
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of...
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
Abstract Objective: To investigate the relationship between brain volume and disability worsening ov...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
ObjectiveTo investigate the relationship between brain volume and disability worsening over ≥3 ...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
Background: Cognitive impairment in primary progressive multiple sclerosis (PPMS) is common and corr...
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of...
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
BACKGROUND: Magnetic resonance imaging (MRI) of brain volume measures are widely used outcomes in se...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
Objective: To investigate the relationship between brain volume and disability worsening over ≥3 yea...
Abstract Objective: To investigate the relationship between brain volume and disability worsening ov...
BACKGROUND: Neuroaxonal loss is a pathological substrate of disability in progressive multiple scler...
ObjectiveTo investigate the relationship between brain volume and disability worsening over ≥3 ...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
Background: Cognitive impairment in primary progressive multiple sclerosis (PPMS) is common and corr...
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of...
Purpose: In secondary progressive Multiple Sclerosis (SPMS), global neurodegeneration as a driver of...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...